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Abstract
Some patients recovered from COVID-19 but the reverse transcription polymerase chain reac-
tion (RT-PCR) for SARS-CoV-2 remains persistently positive. In the evaluation of these patients 
it is important to define the cycle threshold (Ct) value of the RT-PCR test. This article will present 
a case study, address relevant findings and interpretation of the RT-PCR test, and define the 
use of Ct values in defining when a healthcare working may return to work. Our current ap-
proach is to allow to return to work healthcare workers with persistently positive RT-PCR if the 
Ct values are greater than 35.
Introduction
The coronavirus disease of 2019 (COVID-19) pandemic is causing a shocking death toll 
in large because of the high transmissibility of the severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) and the severity of illness in about 20% of cases. [1] It is 
imperative to have a reliable test for early identification of individuals with SARS-CoV-2 
infection. A reliable SARS-CoV-2 test will be instrumental for identification of people 
with the infection, preventing the spread and mitigating the epidemic. [2] Additionally, a 
highly reliable test will allow early interventions that include isolation and appropriate 
medical care of the infected persons that in turn will be translated into the protection of 
the community at risk. 
In a short period of time, there has been substantial progress in the confirmation of 
COVID-19 by a positive SARS-CoV-2 reverse transcription polymerase chain reaction 
(RT-PCR) test in a symptomatic patient. [3] However, there are important uncertainties 
in relation to the best interpretation of the test in different scenarios. [4] It remains to be 
determined what is the best interpretation of a negative RT PCR assay in a symptomatic 
patient. It is becoming an established practice to use two consecutive negative respi-
ratory samples for SARS-CoV-2 at intervals of 24 hours or longer for discontinuation 
of isolation in a convalescent patient with COVID-19. [5] Unfortunately, there are some 
challenges in the best interpretation of test results including communication with high 
risk individuals (e.g. elderly with major comorbidities, etc), those hospitalized patients 
stable enough to return to or enter chronic care facilities, and those recovering from the 
COVID-19 with persistent positive tests. This article will present a case study and ad-
dress relevant findings and interpretation of the diagnostic RT-PCR test in respiratory 
specimens to assist clinicians in their communications and action plans. 
Case Study
A 39-year old registered nurse was evaluated at the hospital employee health clinic due 
to sore throat and fever. She works on the general medicine ward. During her evaluation, 
a nasopharyngeal swab sample was obtained for SARS CoV-2 RT-PCR. The result of the 
RT-PCR test was positive. She was not complaining of cough or shortness of breath. Her 
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social history and past medical history were unremarkable. Her temperature was 101.5° F, heart rate 95 bpm, repira-
tory rate 18 bpm, blood pressure 125/80 mmHg, and oxygen saturation of 96% on room air. The final diagnosis was 
COVID-19. She was advised to begin home isolation, to call if any clinical deterioration, and to plan on returning to 
clinic in 14 days for evaluation before returning to work.   When she returned to the clinic on day 14, she was afebrile 
and had been asymptomatic for 8 days. The repeat SARS CoV-2 RT-PCR was positive. The patient returned to clinic 
on day 22, and the SARS CoV-2 RT-PCR was again positive. She was advised to return to clinic again in 7 days. On day 
29, the repeat RT-PCR was still positive and at this time the patient had been asymptomatic for 23 days. The hospital 
policy stated that a healthcare worker needed to have a demonstrated negative RT-PCR before returning to work. To 
further evaluate the case, the Cycle Threshold (Ct) values were collected for each of the four RT-PCR tests. A graphic 
representation of the Ct values for the patient are depicted in Figure 1. 
Since the last Ct value was elevated at 38, it was considered that the patient was no longer infectious and she was al-
lowed to return to work. 
SARS-CoV-2 RT-PCR Assay
There are many internal and external factors of the SARS-CoV-2 RT PCR test accounting for the optimal diagnostic 
yield.
Internal Factors
This paper is directed to clinicians therefore some internal factors of the SARS-CoV-2 RT PCR assay are beyond the 
aim of this paper. The main internal factors of the RT PCR include the target genes and cycle threshold (Ct)
Genes Target for the SARS-CoV-2 assays.
Currently the most sensitive SARS-CoV-2 RT PCR assays use the genes N1, N2 and E. The Centers for Disease Con-
trol and Prevention (CDC) recommends the genes N1 and N2 encoding the two nucleocapsid proteins and the human 
RNase P gene to confirm the ribonucleic acid (RNA) extraction. On the other hand, the World Health Organization 
(WHO) recommends the assay using the gene E; which requires a confirmatory assay using the RdRp gene. Both assays 
have high analytic sensitivity and specificity for SARS-CoV-2. [6] These two assays are highly specific for SARS-CoV-2 
with no cross-reactivity with other respiratory viruses as reported by Nalla et al. in an evaluation of assays using seven 
different primer-probe sets and one assay kit. [7]
The Basics on the Cycle Threshold
Real-time assay is a type of PCR assay where positive reactions (nucleic acid amplifications) are detected by accumula-
tion of the fluorescent signal in real-time. As the cycles of the real-time PCR continue, the fluorescent signal increases 













First RT-PCR on day 1: 
Ct value 12
Second RT-PCR on day 14: 
Ct value 24
Third RT-PCR on day 22: 
Ct value 32
Fourth RT-PCR on day 29: 
Ct value 38




Figure 1. Schematic representation of the cycle threshold values for the healthcare worker described in the 
case study.
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ber at which the signal crosses the threshold is called a cycle threshold (Ct) (Figure 1). Ct levels are inversely propor-
tional to the amount of the target nucleic acid in the sample. This means that the lower the Ct value the greater the 
amount of the target nucleic acid in the sample and vice-versa.
The cut off for positive and negative Ct for SARS CoV-2 remains unclear. However, a good number of authors recom-
mend a cut off of 40. [2,6,8] It means a test is considered positive if the Ct is < 40 and vice-versa. On the other hand, the 
European Centre for Disease Prevention and Control (ECDC) considers the Ct cut off of 35 and a Ct value > 35 consid-
ers that it could be the result from a contaminant. ECDC recommends all positive results to be confirmed by a second 
gene target. [9] Holshue et al. reported the first case of COVID-19 in the US and the NP Cts on the days 4, 7, 11 and 12 
were 12-18, 23-24, 33-34 and 37-40 respectively. [10] Similar trend of increasing Ct values over time were reported by 
others. [11]  
External factors
Biological Specimens
Samples from the respiratory tract are the most recommended specimens to test for SARS-CoV-2. A nasopharyngeal 
specimen (NP) is the preferred choice for swab-based SARS-CoV-2 testing, but oropharyngeal, mid-turbinate, anterior 
nares samples, sputum and tracheal aspirate and bronchoalveolar lavage also are acceptable specimens. However, the 
yield of a positive test is not the same for each type of specimen and also it depends on the time of the course of the in-
fection. [12] The yield for positive tests were reported to be greater for sputum and bronchoalveolar lavage (BAL) than 
the NP, OP and nasal swabs. [12] Improper collection of respiratory specimens could be sources of false-negative tests. 
SARS-CoV-2 RT-PCR and Timing of Testing
Positive SARS-CoV-2 RT-PCR results have been reported during the incubation time of COVID-19 when patients are 
asymptomatic, during the symptomatic period and lastly during convalescence time when the patients become as-
ymptomatic. On the other hand, there are pending answers to the interpretation of the results of SARS-CoV-2 RT-PCR 
during these three time points of the illness and its translation to infectivity. 
RT-PCR Test during the asymptomatic infection
Rothe et al. reported SARS-CoV-2 RT-PCR from an asymptomatic individual who turned to be the original source of 
infection, also known as “ the index case”, for an individual who became the source for infection of 3 other individuals. 
The transmissions from the asymptomatic index case to patient 1 and from patient 1 to patients 2 to 4 occurred in a total 
of 7 days. All these persons including the index case subsequently developed mild illness characterized by fever and 
mild respiratory symptoms and all had positive SARS-CoV-2 from respiratory sources. In this series, one person had 
a viral load of 108 copies/ml of sputum. [13] The outbreak of COVID-19 on the cruise ship Diamond Princess illustrates 
the SARS-CoV-2 among asymptomatic persons. This outbreak resulted in the SARS-CoV-2 infection of 712 (19.18%) 
persons out of 3,711 passengers and crew members. [14] Ninety (2.4%) persons had asymptomatic SARS-CoV-2 infec-
tion with a median age of 59.5 years. Among the asymptomatic persons, 20% had arterial hypertension and 9% diabetes 
mellitus. The median number of days between the first positive PCR test and the first of the two serial negative PCR 
tests was 9 days. These results of positive SARS-CoV-2 RT-PCR highlights the unique nature of COVID-19, which can 
be asymptomatic and contagious. The confirmation of asymptomatic COVID-19 transmitting the infection to others 
demands to consider universal testing as a strategy to identify the source of infection. 
RT-PCR Test during the symptomatic infection
Zou et al. monitored SARS-CoV-2 viral load of nasal and swab swabs from 18 patients in relation to the symptom onset. 
[15] Lower Ct, higher viral load, were detected soon after the symptoms onset. Interestingly, the viral loads and Ct were 
similar regardless of the presence of the symptoms. In most individuals with symptomatic COVID-19 infection, the 
viral RNA is detectable as early as day 1 of symptoms and peaks within the first week of symptom onset in nasopharyn-
geal swab. [11] In patients without severe COVID-19, the SARS-CoV-2 detection declines by week 3 to undetectable. On 
the other hand, in severe COVID-19 the SARS-CoV-2 detection may persist longer than 3 weeks after illness onset. It 
remains to be determined whether the persistent SARS-CoV-2 is viral infectivity. [11,16] 
  
RT-PCR Test after the symptomatic infection or convalescence
Interpreting the result of a SARS-CoV-2 test depends on the accuracy of the test and the pre-test probability or estimat-
ed risk of disease before testing. Pre-test probability is in relation to the prevalence of the illness under evaluation and it 
influences the accuracy of the test result. The SARS-CoV-2 RT-PCR tests were reported to have a sensitivity of 70% and 
a specificity of 98% (6,16). SARS-CoV-2 RT-PCR has been reported to remain positive in sputum and BAL when the NP 
swabs become negative. [11] Positive SARS-CoV-2 viral cultures have not been reported after day 8 of symptoms onset. 
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[11,16] Though positive SARS-CoV-2 RT-PCR has been reported beyond many weeks following the first positive test, 
it is tempting to think that positive SARS-CoV-2 RT-PCR results after day 8 of symptom onset may not be infectious. 
Persistent positive tests have been reported in some conditions that were not infections e.g. persistent positive acid-fast 
bacilli on staining test paired to negative cultures in patients receiving treatment for tuberculosis with resolving symp-
toms. 
SARS-CoV-2 RT-PCR Sensitivity and Specificity
Because PCR generates two copies of product at each cycle, the difference of 1 in Ct value indicates a difference of the 
target by a two-fold in the input sample. For example, a sample with a Ct of 20 might have 1024-fold higher amount of 
copy number than that with a Ct of 30 (230-20). Low Ct values clearly indicate the presence of high target copy numbers 
in the sample; however, high Ct values (weak positives) could be due to artifactual effects, such as noisy signal, random 
amplification, or potential contamination. All positive results should therefore be confirmed by a second gene target. 
For  this reason, most of real-time PCR test for SARS-CoV-2 use two targets. Only samples with positive results for the 
both of two targets are determined as positive for SARS-CoV-2. In case only one of the two is positive, it is considered 
as “undetermined” and recommended for a second test.
Generally, a real-time PCR shows an extremely high sensitivity, with a detection limit of 1- 10 copies per sample and 
this holds true for the published real-time PCR assays for SARS-CoV2. This means that a sample with a Ct at the cut-
off for positive (e.g., 40) might have 1-10 copies of RNA in the sample. Considering the fact that the target of the most of 
real-time PCR assays for SARS-CoV2 is N gene, which is present in all species of viral mRNA and genomic RNA, high 
Ct values should be carefully interpreted as it cannot indicate the presence of infectious virus or active replications (i.e., 
genomic RNA). In an unpublished study for our group, noinfectious viruses were rescued from clinical NP samples that 
have Ct> 30. 
Positive SARS-CoV-2 RT-PCR and Infectivity
Bullard et al. examined the relationship between SARS-CoV-2 RT-PCR Ct values from respiratory samples, symptom 
onset to test (STT) and infectivity in Vero cell lines culture. [16] Viral growth was seen in only 28.9% of samples. Inter-
estingly, there was no growth in samples with a Ct > 24 or STT > 8 days. They concluded that infectivity may be low 
in patients with Ct >24 and duration of symptoms longer than 8 days. Similarly, Wolfel et al. reported no SARS-CoV-2 
grows in specimens collected after 8 days of the onset of symptoms. [11]
Conclusion
Ct values appear to play an important role when the test-based discontinuation of isolation of the patient is considered. 
It appears that infectivity is low in patients with Ct values greater than 24. In the case study presented in this manu-
script, the healthcare worker was asymptomatic with a Ct value of 38 at day 29 after the initial positive RT-PCR. It was 
considered that the positive RT-PCR likely reflected the presence of residual viral genomic RNA, without the presence 
of live viruses. The healthcare worker was deemed non-infectious and she was allowed to return to work. Our current 
approach is to allow to return to work healthcare workers with persistently positive RT-PCR if the Ct values are greater 
than 35.
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